BIM 44002

Also Known As:

8,18-Nle-12-Trp-34-ITyr-bPTH(1-34)amide; 8,18-norleucyl-12-tryptophyl-34-monoiodinated tyrosine bovine parathyroid hormone (7-34) amide; BIM-44002; Nle(8,18)-D-Trp(12)-monoiodinated Tyr(34)-bPTH(7-34)amide; bPTH(1-34)amide, 8,18-Nle-12-Trp-34-monoiodinated Tyr-; bovine parathyroid hormone(7-34)amide, 8,18-Nle-12-Trp-34-monoiodinated Tyr-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Primary Hyperparathyroidism 12/01/1997 - "Therefore we undertook an investigation to evaluate the potential utility of BIM-44002 in lowering elevated serum calcium in three patients with primary hyperparathyroidism. "
2.	Hyperparathyroidism 12/01/1997 - "We conclude that although the PTH antagonist BIM-44002 was effective both in vitro and in vivo in animals, and it was safe in humans, it was not able to lower serum calcium in patients with hyperparathyroidism. "

Related Drugs and Biologics

1.	Calcium